Goldspire™: A Unique Platform for Personalized, Whole Tumor-Derived Immunotherapy with Compelling Clinical Data in Glioblastoma
Time: 2:00 pm
day: Conference Day 2
Details:
- Turning the complexity of the tumor against itself
- Personalized Immunotherapy stimulating tumor Immunogenic Cell Death
- Compelling Phase 1b data leading into ongoing Phase 2b
